Drug information for MYCAMINE

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
INJECTABLE; INJECTION	50MG	Prescription		MICAFUNGIN SODIUM	micafungin	ASTELLAS	21506 2011-06-27 Label 2011-06-27 Label 2011-06-10 Letter 2011-06-10 Letter 2008-01-24 Letter 2008-01-24 Label 2007-08-07 Label 2007-08-07 Letter 2006-07-03 Letter 2006-06-28 Label 2005-08-24 Review 2005-03-18 Letter 2005-03-18 Label 2005-03-18 Other
INJECTABLE; INJECTION	50MG	Prescription		MICAFUNGIN SODIUM	micafungin	FUJISAWA HLTHCARE	21754 2007-12-06 Review 2005-03-18 Letter 2005-03-18 Label 2005-03-18 Other
INJECTABLE; IV (INFUSION)	100MG/VIAL	Prescription	(Reference Drug)	MICAFUNGIN SODIUM	micafungin	ASTELLAS	21506 2011-06-27 Label 2011-06-27 Label 2011-06-10 Letter 2011-06-10 Letter 2008-01-24 Letter 2008-01-24 Label 2007-08-07 Label 2007-08-07 Letter 2006-07-03 Letter 2006-06-28 Label 2005-08-24 Review 2005-03-18 Letter 2005-03-18 Label 2005-03-18 Other
INJECTABLE; IV (INFUSION)	50MG/VIAL	Prescription	(Reference Drug)	MICAFUNGIN SODIUM	micafungin	ASTELLAS	"

Drug Adverse Effects information for MYCAMINE

Role code	Indications	Reaction	# Reports
PS	ACUTE MYELOID LEUKAEMIA	GENERAL PHYSICAL HEALTH DETERIORATION	2
PS	ACUTE MYELOID LEUKAEMIA	NO ADVERSE EVENT	2
PS	ACUTE RESPIRATORY DISTRESS SYNDROME	BRONCHOPULMONARY ASPERGILLOSIS	1
PS	ACUTE RESPIRATORY DISTRESS SYNDROME	CAPILLARY LEAK SYNDROME	1
PS	ACUTE RESPIRATORY DISTRESS SYNDROME	ENTEROCOCCAL SEPSIS	1
PS	ACUTE RESPIRATORY DISTRESS SYNDROME	GRAFT VERSUS HOST DISEASE	1
PS	ANTIFUNGAL PROPHYLAXIS	DEATH	1
PS	ANTIFUNGAL PROPHYLAXIS	NO ADVERSE EVENT	1
PS	B-CELL LYMPHOMA	SYSTEMIC CANDIDA	1
PS	CANDIDIASIS	BONE MARROW TRANSPLANT	1
PS	CANDIDIASIS	THROMBOTIC THROMBOCYTOPENIC PURPURA	1
PS	FUNGAL INFECTION	BRONCHOPULMONARY ASPERGILLOSIS	1
PS	FUNGAL INFECTION	CAPILLARY LEAK SYNDROME	1
PS	FUNGAL INFECTION	ENTEROCOCCAL SEPSIS	1
PS	FUNGAL INFECTION	GRAFT VERSUS HOST DISEASE	1
PS	FUNGAL INFECTION	INCORRECT DOSE ADMINISTERED	1
PS	FUNGAL INFECTION	NEONATAL CHOLESTASIS	1
PS	FUNGAL INFECTION	OFF LABEL USE	1
PS	FUNGAL INFECTION	RASH	2
PS	FUNGAL INFECTION	SWELLING FACE	2
PS	FUNGAL INFECTION	SYSTEMIC CANDIDA	1
PS	GRAFT VERSUS HOST DISEASE	BRONCHOPULMONARY ASPERGILLOSIS	1
PS	GRAFT VERSUS HOST DISEASE	CAPILLARY LEAK SYNDROME	1
PS	GRAFT VERSUS HOST DISEASE	ENTEROCOCCAL SEPSIS	1
PS	GRAFT VERSUS HOST DISEASE	GRAFT VERSUS HOST DISEASE	1
PS	IMMUNOSUPPRESSION	BRONCHOPULMONARY ASPERGILLOSIS	1
PS	IMMUNOSUPPRESSION	CAPILLARY LEAK SYNDROME	1
PS	IMMUNOSUPPRESSION	ENTEROCOCCAL SEPSIS	1
PS	IMMUNOSUPPRESSION	GRAFT VERSUS HOST DISEASE	1
PS	PNEUMONIA	BRONCHOPULMONARY ASPERGILLOSIS	1
PS	PNEUMONIA	CAPILLARY LEAK SYNDROME	1
PS	PNEUMONIA	ENTEROCOCCAL SEPSIS	1
PS	PNEUMONIA	GRAFT VERSUS HOST DISEASE	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	BLOOD CULTURE POSITIVE	2
PS	PRODUCT USED FOR UNKNOWN INDICATION	DEATH	10
PS	PRODUCT USED FOR UNKNOWN INDICATION	RESPIRATORY FAILURE	2
PS	PRODUCT USED FOR UNKNOWN INDICATION	SEPSIS	2
PS	PROPHYLAXIS	CANDIDIASIS	1
PS	PROPHYLAXIS	DRUG INEFFECTIVE	1
PS	SEPTIC SHOCK	BRONCHOPULMONARY ASPERGILLOSIS	2
PS	SEPTIC SHOCK	CAPILLARY LEAK SYNDROME	2
PS	SEPTIC SHOCK	ENTEROCOCCAL SEPSIS	2
PS	SEPTIC SHOCK	GRAFT VERSUS HOST DISEASE	2
SS	B-CELL LYMPHOMA	SYSTEMIC CANDIDA	1
SS	FUNGAL INFECTION	SYSTEMIC CANDIDA	1
SS	PRODUCT USED FOR UNKNOWN INDICATION	ABDOMINAL PAIN	3
SS	PRODUCT USED FOR UNKNOWN INDICATION	CHILLS	3
SS	PRODUCT USED FOR UNKNOWN INDICATION	DEATH	3
SS	PRODUCT USED FOR UNKNOWN INDICATION	INFUSION RELATED REACTION	3
SS	SYSTEMIC CANDIDA	ABDOMINAL PAIN	1
SS	SYSTEMIC CANDIDA	CHILLS	1
SS	SYSTEMIC CANDIDA	DEATH	1
SS	SYSTEMIC CANDIDA	INFUSION RELATED REACTION	1
C	ANXIETY	UPPER RESPIRATORY TRACT INFECTION	1
C	CROHN'S DISEASE	ABDOMINAL ABSCESS	3
C	CROHN'S DISEASE	ANAEMIA	3
C	CROHN'S DISEASE	DEVICE RELATED SEPSIS	3
C	CROHN'S DISEASE	FUNGAEMIA	3
C	GLIOBLASTOMA	UPPER RESPIRATORY TRACT INFECTION	2
C	PAIN	UPPER RESPIRATORY TRACT INFECTION	1
C	PROPHYLAXIS	UPPER RESPIRATORY TRACT INFECTION	2
I	ANTIBIOTIC THERAPY	COAGULATION FACTOR V LEVEL DECREASED	2
I	ANTIBIOTIC THERAPY	CYTOLYTIC HEPATITIS	2
I	ANTIBIOTIC THERAPY	DRUG INTERACTION	2
I	ATRIAL FIBRILLATION	COAGULATION FACTOR V LEVEL DECREASED	2
I	ATRIAL FIBRILLATION	CYTOLYTIC HEPATITIS	2
I	ATRIAL FIBRILLATION	DRUG INTERACTION	2

Ads by Google